These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33604875)

  • 1. Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and Adjuvants.
    Lin SP; Calcagno A; Letendre SL; Ma Q
    Curr Top Behav Neurosci; 2021; 50():517-545. PubMed ID: 33604875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-associated neurocognitive disorders: antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes.
    Cross HM; Combrinck MI; Joska JA
    S Afr Med J; 2013 Sep; 103(10):758-62. PubMed ID: 24079630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Antiretroviral Medication Neuropenetrance and Neurocognitive Outcomes in HIV+ Adults: A Review of the Literature Examining the Central Nervous System Penetration Effectiveness Score.
    Arentoft A; Troxell K; Alvarez K; Aghvinian M; Rivera Mindt M; Cherner M; Van Dyk K; Razani J; Roxas M; Gavilanes M
    Viruses; 2022 May; 14(6):. PubMed ID: 35746623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of antiretroviral therapy with high central nervous system penetration on HIV-related cognitive impairment: a systematic review and meta-analysis.
    Webb AJ; Borrelli EP; Vyas A; Taylor LE; Buchanan AL
    AIDS Care; 2023 Nov; 35(11):1635-1646. PubMed ID: 35850626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders.
    Sharma I
    HIV Med; 2021 Oct; 22(9):783-790. PubMed ID: 34291558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
    Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.
    Joseph SB; Gianella S; Burdo TH; Cinque P; Gisslen M; Letendre S; Nath A; Morgello S; Ndhlovu LC; Spudich S
    J Infect Dis; 2023 Mar; 227(Suppl 1):S3-S15. PubMed ID: 36930640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.
    Ghura S; Gross R; Jordan-Sciutto K; Dubroff J; Schnoll R; Collman RG; Ashare RL
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):694-714. PubMed ID: 31834620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.
    Marra CM; Zhao Y; Clifford DB; Letendre S; Evans S; Henry K; Ellis RJ; Rodriguez B; Coombs RW; Schifitto G; McArthur JC; Robertson K;
    AIDS; 2009 Jul; 23(11):1359-66. PubMed ID: 19424052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.
    Santos GMA; Locatelli I; Métral M; Calmy A; Lecompte TD; Nadin I; Hauser C; Cusini A; Hasse B; Kovari H; Tarr P; Stoeckle M; Fux C; Di Benedetto C; Schmid P; Darling KEA; Du Pasquier R; Cavassini M;
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz277. PubMed ID: 31304188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility.
    Fabbiani M; Grima P; Milanini B; Mondi A; Baldonero E; Ciccarelli N; Cauda R; Silveri MC; De Luca A; Di Giambenedetto S
    Antivir Ther; 2015; 20(4):441-7. PubMed ID: 25516553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.
    Letendre S; Marquie-Beck J; Capparelli E; Best B; Clifford D; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Morgello S; Simpson D; Grant I; Ellis RJ;
    Arch Neurol; 2008 Jan; 65(1):65-70. PubMed ID: 18195140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder.
    Letendre S
    Top Antivir Med; 2011 Nov; 19(4):137-42. PubMed ID: 22156215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated neurocognitive disorders and central nervous system drug penetration: what next?
    Marra CM
    Antivir Ther; 2015; 20(4):365-7. PubMed ID: 25781980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive impairment and neuroCART.
    Wright E
    Curr Opin HIV AIDS; 2011 Jul; 6(4):303-8. PubMed ID: 21546833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV, antiretroviral therapies, and the brain.
    Liner KJ; Ro MJ; Robertson KR
    Curr HIV/AIDS Rep; 2010 May; 7(2):85-91. PubMed ID: 20425562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study.
    Force G; Ghout I; Ropers J; Carcelain G; Marigot-Outtandy D; Hahn V; Darchy N; Defferriere H; Bouaziz-Amar E; Carlier R; Dorgham K; Callebert J; Peytavin G; Delaugerre C; de Truchis P;
    J Antimicrob Chemother; 2021 Feb; 76(3):743-752. PubMed ID: 33179033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antiretroviral therapy on cognitive impairment.
    Liner KJ; Hall CD; Robertson KR
    Curr HIV/AIDS Rep; 2008 May; 5(2):64-71. PubMed ID: 18510891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals.
    Ceccarelli G; Brenchley JM; Cavallari EN; Scheri GC; Fratino M; Pinacchio C; Schietroma I; Fard SN; Scagnolari C; Mezzaroma I; Vullo V; d'Ettorre G
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29160817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.